Literature DB >> 22713293

Height, weight, BMI and ovarian cancer survival.

Joanne Kotsopoulos1, Joel R K Moody, Isabel Fan, Barry Rosen, Harvey A Risch, John R McLaughlin, Ping Sun, Steven A Narod.   

Abstract

OBJECTIVES: Ovarian cancer is a highly fatal gynecologic malignancy. Prognosis is primarily based on clinicopathologic features. There is interest in the role of modifiable factors including overweight and obesity, although data to date have been inconclusive. Here we evaluate the relationship between body size and ovarian cancer survival among 1423 women diagnosed with epithelial ovarian cancer in a large population-based study.
METHODS: Information on risk factors and characteristics was collected by telephone. Vital status was determined both by computerized record-linkage and by chart review. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for height, weight and body mass index (BMI) in association with ovarian cancer-specific mortality.
RESULTS: Height, weight and BMI 5 years prior to diagnosis did not significantly predict ovarian cancer survival in this study. The HR for ovarian cancer-specific mortality for women with a weight of >61 kg compared with >50-55 kg was 0.91 (95%CI 0.71-1.20). The HR among women with a BMI≥30 kg/m2 compared to 18.5-<25 kg/m2 was 1.11 (95%CI 0.87-1.42). These findings did not vary by histologic subtype.
CONCLUSIONS: Our results do not support a role of height, adult weight or adiposity in ovarian cancer prognosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22713293     DOI: 10.1016/j.ygyno.2012.05.038

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer.

Authors:  Rebecca Ann Previs; Joshua Kilgore; Renatta Craven; Gloria Broadwater; Sarah Bean; Sara Wobker; Megan DiFurio; Victoria Bae-Jump; Paola A Gehrig; Angeles Alvarez Secord
Journal:  Int J Gynecol Cancer       Date:  2014-05       Impact factor: 3.437

2.  Anthropometric characteristics and ovarian cancer risk and survival.

Authors:  Albina N Minlikeeva; Kirsten B Moysich; Paul C Mayor; John L Etter; Rikki A Cannioto; Roberta B Ness; Kristen Starbuck; Robert P Edwards; Brahm H Segal; Sashikant Lele; Kunle Odunsi; Brenda Diergaarde; Francesmary Modugno
Journal:  Cancer Causes Control       Date:  2018-01-11       Impact factor: 2.506

Review 3.  Impact of Body Weight and Body Composition on Ovarian Cancer Prognosis.

Authors:  Sarah A Purcell; Sarah A Elliott; Candyce H Kroenke; Michael B Sawyer; Carla M Prado
Journal:  Curr Oncol Rep       Date:  2016-02       Impact factor: 5.075

4.  Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer.

Authors:  Hui Zheng; Renquan Lu; Suhong Xie; Xuemei Wen; Hongling Wang; Xiang Gao; Lin Guo
Journal:  Cancer Sci       Date:  2015-04-13       Impact factor: 6.716

5.  Urinary interleukin-1β levels among gynecological patients.

Authors:  Kamisha T Woolery; Mitchel S Hoffman; Joshua Kraft; Santo V Nicosia; Ambuj Kumar; Patricia A Kruk
Journal:  J Ovarian Res       Date:  2014-11-18       Impact factor: 4.234

6.  A Delay from Diagnosis to Treatment Is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer.

Authors:  Darren Dolly; Andreea Mihai; B J Rimel; Louis Fogg; Jacob Rotmensch; Alfred Guirguis; Edgardo Yordan; Summer Dewdney
Journal:  Front Oncol       Date:  2016-02-12       Impact factor: 6.244

7.  Impact of body mass index on ovarian cancer survival varies by stage.

Authors:  Elisa V Bandera; Valerie S Lee; Bo Qin; Lorna Rodriguez-Rodriguez; C Bethan Powell; Lawrence H Kushi
Journal:  Br J Cancer       Date:  2017-06-06       Impact factor: 7.640

8.  Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.

Authors:  Shana J Kim; Barry Rosen; Isabel Fan; Anna Ivanova; John R McLaughlin; Harvey Risch; Steven A Narod; Joanne Kotsopoulos
Journal:  Br J Cancer       Date:  2017-02-16       Impact factor: 7.640

9.  Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study.

Authors:  Dengfeng Wang; Guonan Zhang; Chunrong Peng; Yu Shi; Xunwei Shi
Journal:  J Ovarian Res       Date:  2021-03-27       Impact factor: 4.234

10.  Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis.

Authors:  Fausto Petrelli; Alessio Cortellini; Alice Indini; Gianluca Tomasello; Michele Ghidini; Olga Nigro; Massimiliano Salati; Lorenzo Dottorini; Alessandro Iaculli; Antonio Varricchio; Valentina Rampulla; Sandro Barni; Mary Cabiddu; Antonio Bossi; Antonio Ghidini; Alberto Zaniboni
Journal:  JAMA Netw Open       Date:  2021-03-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.